Cano Health, Maxeon Solar Technologies, Velo3D And Other Big Stocks Moving Lower In Friday's Pre-Market Session

U.S. stock futures traded mixed this morning on Friday. Here are some big stocks recording losses in today’s pre-market trading session.

Cano Health, Inc. (NYSE:CANO) shares tumbled 41.5% to $0.89 in pre-market trading after the company reported worse-than-expected second-quarter financial results.

Maxeon Solar Technologies, Ltd. (NASDAQ:MAXN) shares dipped 25.7% to $16.55 in pre-market trading after the company reported mixed second-quarter financial results and issued FY23 revenue guidance below estimates.

Markforged Holding Corporation (NYSE:MKFG) fell 8.5% to $1.40 in pre-market trading following second-quarter results.

Grupo Aval Acciones y Valores S.A. (NYSE:AVAL) fell 8.3% to $2.42 in pre-market trading.

Velo3D, Inc. (NYSE:VLD) shares fell 7.7% to $1.67 in pre-market trading after the company reported worse-than-expected second-quarter financial results and announced an offering of $70 million of senior secured convertible notes.

Blend Labs, Inc. (NYSE:BLND) shares declined 7.7% to $1.32 in pre-market trading. Blend Labs shares gained 17% on Thursday after the company reported better-than-expected second-quarter financial results and issued third-quarter consolidated revenue guidance.

Senseonics Holdings, Inc. (NYSE:SENS) shares fell 7.5% to $0.6818 in pre-market trading following weak quarterly sales.

Eastman Kodak Company (NYSE:KODK) fell 6.3% to $4.48 in pre-market trading.

Beneficient (NASDAQ:BENF) shares fell 6.3% to $2.24 in pre-market trading after jumping 28% on Thursday.

Precigen, Inc. (NASDAQ:PGEN) shares declined 5.3% to $1.44 in pre-market trading. Precigen shares gained over 22% on Thursday after the company announced FDA confirmation that the ongoing Phase 1/2 study of PRGN-2012 AdenoVerse Immunotherapy will serve as the pivotal study to support accelerated approval.

 

Now Read This: Fear & Greed Index Remains In 'Greed' Zone Following Inflation Data

Don’t forget to check out our premarket coverage here